Chennai Oscar Bio Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 05-07-2024
- Paid Up Capital ₹ 2.00 M
as on 05-07-2024
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 7.07%
(FY 2018)
- Profit -20.66%
(FY 2018)
- Ebitda 3.35%
(FY 2018)
- Net Worth 8.17%
(FY 2018)
- Total Assets 0.42%
(FY 2018)
About Chennai Oscar Bio Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sekar Chettiar and Baalachandar Sekar serve as directors at the Company.
- CIN/LLPIN
U24200TN2013PTC090674
- Company No.
090674
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chennai Oscar Bio Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sekar Chettiar  | Director | 18-Apr-2013 | Current |
| Baalachandar Sekar | Director | 05-Nov-2014 | Current |
Financial Performance of Chennai Oscar Bio Pharmaceuticals.
Chennai Oscar Bio Pharmaceuticals Private Limited, for the financial year ended 2018, experienced modest growth in revenue, with a 7.07% increase. The company also saw a substantial fall in profitability, with a 20.66% decrease in profit. The company's net worth moved up by a moderate rise of 8.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chennai Oscar Bio Pharmaceuticals?
In 2018, Chennai Oscar Bio Pharmaceuticals had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Om Dhan Naturals Private LimitedActive 3 years 3 monthsSekar Chettiar and Baalachandar Sekar are mutual person
- Krebz Healthcare Private LimitedActive 20 years 10 months
Sekar Chettiar and Baalachandar Sekar are mutual person
- Guruv Pharmaceutical Private LimitedActive 5 years 21 days
Sekar Chettiar and Baalachandar Sekar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chennai Oscar Bio Pharmaceuticals?
Unlock and access historical data on people associated with Chennai Oscar Bio Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chennai Oscar Bio Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chennai Oscar Bio Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
